GLG surveyed senior leaders at $1B+ global pharma and medtech companies to uncover GenAI adoption trends, enabling the client to align their strategy, messaging, and partnerships with stakeholder priorities, concerns, and maturity levels.
Access to the Right Decision Makers
GLG identified and recruited hard-to-reach senior leaders with deep experience in AI adoption, clinical operations, medical affairs, and vendor management across geographies and regulated environments.
Strategic Insights
The team delivered targeted insights on AI maturity, governance gaps, and buyer intent within a tight timeline. GLG's expert network, research precision, and speed enabled the client to act decisively and position themselves as a trusted partner in an emerging, complex AI landscape.
